FILE:FMC/FMC-8K-20040921114216.txt.gz
EVENTS:	Regulation FD Disclosure
TEXT:
ITEM: Regulation FD Disclosure
 
 
 
 
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
 
 
 
On September 20, 2004, William G. Walter, Chairman, President and Chief Executive Officer, addressed the Bank of America Securities 34
th
Annual Investment Conference held in San Francisco, California. Slides used in his presentation at the meeting are included herein as an exhibit. These slides may also be accessed at the company's website (www.fmc.com) and will be available for a period of at least thirty days.
 
This report is not deemed "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section.
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
Date: September 21, 2004
 
 
 

Exhibit 99.1
 
FMC Corporation
Bank of America
34th Annual Investment Conference
September 20, 2004
William G. Walter
Chairman, President and CEO
 
Disclaimer
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
These slides and the accompanying presentation contain "forward-looking statements" that represent management's best judgment as of the date hereof based on information currently available. Actual results of the Company may differ materially from those contained in the forward-looking statements.
Additional information concerning factors that may cause results to differ materially from those in the forward-looking statements is contained in the Company's periodic reports filed under the Securities Exchange Act of 1934, as amended.
The Company undertakes no obligation to update or revise these forward-looking statements to reflect new events or uncertainties.
1
 
Use of Non-GAAP Terms
These slides contain certain "non-GAAP financial terms" which are defined below and on FMC's Investor Relations web site (http://ir.fmc.com) in the Glossary of Financial Terms section. In addition, in the Conference Calls and Presentations section of the web site, we have provided reconciliations of non-GAAP terms to the closest GAAP term. Lastly, these slides contain references to segment financial items which are presented in detail in Note 19 of FMC's 2003 Form 10-K.
EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) is the sum of Income (loss) from continuing operations before income taxes and cumulative effect of change in accounting principle and Depreciation and Amortization.
EBITDA Margin is the quotient of EBITDA (defined above) and Revenue.
ROIC (Return on Invested Capital) is the sum of Earnings from continuing operations before restructuring and other charges (gains) and after-tax Interest expense divided by the sum of Short-term debt, Current portion of long-term debt, Long-term debt and Total shareholders' equity.
Free Cash Flow is the sum of Cash provided (required) by operating activities and Cash required by discontinued operations less Cash required by investing activities.
2
 
FMC Corporation
Diversified chemical company with leading market positions in industrial, consumer and agricultural markets globally
($ million, LTM 6/30/04)
FMC
Sales: $2,017.4
EBITDA: $343.5
Margin: 17.0%
Industrial Chemicals
Sales: $793.1
EBITDA: $96.6
Margin: 12.2%
Specialty Chemicals
Sales: $526.4
EBITDA: $132.4
Margin: 25.2%
Agricultural Products
Sales: $703.3
EBITDA: $145.5
Margin: 20.7%
3
 
Our Commitments
Unlocking value and creating a faster growing FMC
Realize the operating leverage inherent within FMC
Double-digit growth in earnings* Industrial Chemicals recovery
Continued growth in Specialty Chemicals and Agricultural Products
Create greater financial flexibility
Reduce net debt to $600 million by the end of 2006 Regain an investment grade credit rating
Focus the portfolio on higher growth businesses
Manage Specialty Chemicals and Agricultural Products for growth
Manage Industrial Chemicals for cash Divest any business that cannot sustain our cost of capital Improve ROIC to 12 percent minimum by 2006
* Before restructuring and other charges
4
 
Strong First Half 2004 Performance
Outstanding performance in Agricultural Products
A 21% year-over-year increase in sales Even stronger earnings growth of over 100%
Improvement in Industrial Chemicals
$20 million in annual restructuring savings at Astaris
Higher selling prices in hydrogen peroxide, phosphorus chemicals and domestic soda ash
Significant growth in soda ash export volumes
Sold-out U.S. soda ash market and tight hydrogen peroxide market
Steady top-line growth in our Specialty Chemicals franchise
Continued reduction in net debt
Despite last keepwell payment to Astaris of $36 million and the seasonal working capital build in Agricultural Products
5
 
On Track to Exceed Our Commitments
2003 Actual Jan. 2004 Outlook July 2004 Outlook
Earnings per Share ($)* 1.90 2.30 - 2.50 3.10 - 3.25
Annual Reduction in Net Debt 47 20 - 40 40 - 60 ($ millions)
Return on Invested Capital (%) 8.4 8.9 10.5
* Before restructuring and other charges
6
 
Turn in Financial Performance
We remain on track to deliver a sustained multi-year recovery in sales and earnings
Sales*, $ millions
2,200 2,000 1,800 1,600 1,400 1,200 1,000
2000 2001 2002 2003 2004E
6.00 5.00 4.00 3.00 2.00 1.00 -
EPS**, $
Sales EPS
* 2004E sales are calculated using last twelve month's sales ended 6/30/04.
** 2004E EPS are consensus earnings as of September 17, 2004.
7
 
Industrial Chemicals to be the Primary Driver of Higher Earnings
Millions
$250 $200 $150 $100 $50 $0 $194 $208 $177 $133 $130 $94 $97
1998 1999 2000 2001 2002 2003 2004 (LTM)
25% 20% 15% 10% 5% 0%
Margin
EBITDA Capital Spending EBITDA Margin (%)
8
 
Last Peak
Sold-out U.S. Soda Ash Industry
U.S. Bulk
Soda Ash Price Index (1990 = 1.0)
1.2 1.1 1 0.9 0.8
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
2004F 100 95 90 85
Effective Capacity Utilization (%, U.S.)
Price Index Effective Capacity Util.
9
 
Rising Domestic Hydrogen Peroxide Prices
Last Peak
Hydrogen Peroxide
Price Index (1994=1.0)
1.2 1.1 1 0.9 0.8 0.7 0.6
1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
2004F 100 95 90 85 80 75 70
Effective Capacity Utilization
(%, North America)
Price Index Effective Capacity Util.
10
 
Turnaround In Domestic Phosphorus
Significant restructuring at Astaris
Plant closures and product line transitions are completed
Annualized savings of $40 million are in place (a $20 million benefit to FMC's operating profit)
North American market dynamics are improving
Astaris capacity reductions have tightened domestic supply
Strong euro has reduced import pressures from Europe
Chinese P4 supply has greatly subsided due to energy constraints
Broad-based price increases of 4-7 percent are expected to have favorable impact on 2005 contracts
De-leveraging and refinancing Astaris
$36 million of keepwells paid during Q2 2004
Astaris is now debt free
Possible refinancing of Astaris in late 2004 or 2005
11
 
Platforms in Specialty Chemicals To Drive Top-line Growth
Millions
$140 $120 $100 $80 $60 $40 $20 $0 $115 $110 $127 $122 $116 $132 $132
1998 1999 2000 2001 2002 2003 2004 (LTM)
30% 25% 20% 15% 10% 5% 0%
Margin EBITDA Capital Spending EBITDA Margin (%)
BioPolymer:
Attractive end-use markets growing at 3 to 6% per year
Global leader in all three product lines
Lithium:
Focus on specialty markets growing at 4 to >10% per year
12
 
Agricultural Products to Remain Strong
Millions
$160 $140
$120 $100 $80 $60
$40 $20 $0 $106 $87 $114 $101 $99 $111 $145
1998 1999 2000 2001 2002 2003 2004 (LTM)
25% 20% 15% 10% 5% 0%
Margin
EBITDA Capital Spending EBITDA Margin (%)
Global farm economy expected to remain strong through 2005
Refocused strategy yielding projected benefits:
Significant cost savings from outsourcing and cost reduction
Improved product mix through new labels and niche market focus
Growth from newly licensed products
13
 
Significant Improvement to Cash Flow
$ millions
Cash Flow Components 2004 2005 2006 2007
EBITDA* $368
Pre-Tax Interest** 84
Capital Expenditures 90
Cash Taxes 15
Environmental 25
Increasing
Decreasing
Relatively Flat
Relatively Flat
Relatively Flat
Phosphorus-Related:
Pocatello 35 <10 <10 <10
Keepwells 36   
* Calculated using mid-point of earnings per share guidance before restructuring and other charges provided on July 28, 2004. See reconciliation under "Conference Calls" at http://ir.fmc.com.
** Includes $82 million of GAAP interest expense and $2 million of affiliate interest expense.
14
 
In Summary
Great businesses, each generating EBITDA of over $100 million
Industrial Chemicals earnings are currently $50 million below mid-cycle and $100 million below peak
Steady growth in the balance of the portfolio
Low capital expenditure requirements
Significantly improving free cash flow
15
 
Terrific Stock Performance
The Street has recognized the deep value opportunity and has driven strong stock performance
Price, $/share
50 40 30 20 10 0
3/3/2003 5/3/2003 7/3/2003 9/3/2003
11/3/2003
1/3/2004 3/3/2004 5/3/2004 7/3/2004 9/3/2004
16
 
Yet Still, FMC Remains Grossly Undervalued
Enterprise Value/EBITDA (LTM)
25 20 15 10 5 0
Lyondell Lubrizol Olin Valspar IMC Scotts Crompton Ferro Sensient Airgas Albemarle Cytec RPM Cabot Min. Tech FMC
S&P 400 Midcap Chemicals
As of the close on September 16th, 2004
17
 
FMC Corporation


